2021
DOI: 10.1016/j.jconrel.2021.07.019
|View full text |Cite
|
Sign up to set email alerts
|

Acoustic Cluster Therapy (ACT®) enhances accumulation of polymeric micelles in the murine brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 43 publications
0
5
0
Order By: Relevance
“…The focused ultrasound creates reversible BBB permeability enhancement by concentrating acoustic energy on a focal spot and disrupting tight junctions [ 139 ]. The focused ultrasound intensity parameters can be specified in the units of the acoustic power (0.42–1.84 W [ 172 , 173 ]), power density (0.5–1.0 W/cm 2 [ 174 ]), sound pressure (1000 kPa [ 175 ]), peak acoustic pressure (in the range of 0.09–0.80 MPa [ 173 , 176 , 177 ]), and focal acoustic pressure in the brain (0.8 MPa [ 178 ]). The ultrasonic transducer frequency also may be different and varies from 0.5 to 2.7 MHz [ 62 , 176 , 178 , 179 ].…”
Section: Physical Methods Of Histohematic Barriers Permeability Enhan...mentioning
confidence: 99%
See 2 more Smart Citations
“…The focused ultrasound creates reversible BBB permeability enhancement by concentrating acoustic energy on a focal spot and disrupting tight junctions [ 139 ]. The focused ultrasound intensity parameters can be specified in the units of the acoustic power (0.42–1.84 W [ 172 , 173 ]), power density (0.5–1.0 W/cm 2 [ 174 ]), sound pressure (1000 kPa [ 175 ]), peak acoustic pressure (in the range of 0.09–0.80 MPa [ 173 , 176 , 177 ]), and focal acoustic pressure in the brain (0.8 MPa [ 178 ]). The ultrasonic transducer frequency also may be different and varies from 0.5 to 2.7 MHz [ 62 , 176 , 178 , 179 ].…”
Section: Physical Methods Of Histohematic Barriers Permeability Enhan...mentioning
confidence: 99%
“…The ultrasonic transducer frequency also may be different and varies from 0.5 to 2.7 MHz [ 62 , 176 , 178 , 179 ]. A custom-built dual-frequency ultrasound transducer can be applied [ 177 ]. Depending on the ultrasound power and frequency, the maximum NP diameter reaches 100–200 nm for cell-membrane-cloaked liposomes [ 174 ], lipid–polymer hybrid NPs [ 172 ], and PEGylated Au NPs [ 176 ] and about 50–100 nm for polymeric micelles [ 177 ] and sulfur NPs [ 175 ].…”
Section: Physical Methods Of Histohematic Barriers Permeability Enhan...mentioning
confidence: 99%
See 1 more Smart Citation
“…In vivo studies have reported that the transition from microclusters to large ACT Ò bubbles can be achieved using ultrasound frequencies of 0.5 to 8 MHz (Healey et al 2016;van Wamel et al 2016a;Kotopoulis et al 2017;Bush et al 2020). Although a small, enhanced drug uptake was observed after this first step, a subsequent ultrasound exposure resulted in a considerably increased drug uptake, indicating that both the activation step and the subsequent sonication called the enhancement step are required (van Wamel et al 2016a;Olsman et al 2021). During the enhancement step, the ACT Ò bubbles are exposed to low-frequency (0.3À1.0 MHz) ultrasound at low pressures causing the ACT Ò bubbles to oscillate (Sontum et al 2015;Healey et al 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Mice with subcutaneously growing pancreatic tumors treated with paclitaxel and ACT Ò exhibited reduced tumor growth compared with those treated with paclitaxel alone (Kotopoulis et al 2017). ACT Ò has also been reported to temporarily increase the permeability of the bloodÀbrain barrier, allowing polymeric nanoparticles to enter the brain parenchyma (Aslund et al 2017;Olsman et al 2021). A clinical study has been initiated in which liver metastases of colorectal cancer patients are being treated with standard chemotherapy combined with ACT Ò (ClinicalTrials.gov identifier: NCT04021277).…”
Section: Introductionmentioning
confidence: 99%